2nd Annual Companion Diagnostics - CDx Summit

October 2016



Hotel Riu Plaza Berlin

Martin-Luther-Straße 1, 10777

About Summit

This premier B2B event provides the appropriate platform to engage and discuss ideas with your peers, while facilitating a professional atmosphere and environment for good company representation and development. The summit will shed light on current challenges, best practice and offer an inside view of the future of Companion Diagnostics. We will discuss key findings, including critical insights, as well as recommendations for driving efficient strategies in Companion Diagnostics landscape.

Who Should Attend

CEOs, Companion Diagnostics Vice-Presidents, Directors, Chief Medical Officers, Including:

  • Companion Diagnostics
  • Personalized Healthcare
  • Medical Sciences
  • Translational Medicine
  • Worldwide Regulatory Strategy
  • Oncology
  • Drug Development
  • Molecular Diagnostics
  • Biomarkers
  • Experimental Medicine
  • Clinical Trials
  • Corporate Development & Ventures
  • Genomics

From Industries Including: 

  • Pharmaceutical
  • Medical Devices
  • Testing Laboratories
  • Consultancy
  • Biotechnology
  • Research Institutes
  • CD Entities
Key Practical Learning Points of the Summit

What is the future of CDx & CoDx in an age of personalized healthcare?
Leveraging your company perspectives VS the latest trends in CDx & CoDx towards applications for new and potential biomarker-driven therapies
Creating a successful roadmap for CDx adoption in oncology and beyond
Building effective risk-mitigating strategies for CDx & Drug co-development: from novel biomarkers discovery to regulatory; reimbursement; commercialization for better patient-centered health & economic outcomes
Harmonizing partnerships in achieving a fitting match of tech science advancements vs CDx & novel therapies development to accelerate breakthroughs in an era of precision medicine
Dr. Reinhard Ortmann

Director of the Companion Diagnostic Commercialization


Dr. David Brindley

Senior Research Fellow in Healthcare Translation

University of Oxford’s Department of Padediatrics

Dr. Eddie Blair

Managing Director

Integrated Medicines Ltd (UK)

Ivan Malagurski

International Product Manager Companion Diagnostics

Roche Diagnostics, Switzerland

Dr. Claudia Dollins

Associate Director Global Regulatory Affairs CD

Merck KGaA

Vishal Sikri

VP & Managing Director Global Commercial Operations

Sysmex Inostics, US



Sponsors and Partners